{"PubmedArticle": [{"MedlineCitation": {"OtherID": [], "SpaceFlightMission": [], "KeywordList": [["Ozoile", "cytokines", "inflammation", "intestinal epithelial cells", "monocytes", "stable ozonides"]], "CitationSubset": [], "InvestigatorList": [], "OtherAbstract": [], "GeneralNote": [], "PMID": "36826032", "DateRevised": {"Year": "2023", "Month": "02", "Day": "28"}, "Article": {"Language": ["eng"], "ArticleDate": [{"Year": "2023", "Month": "02", "Day": "05"}], "ELocationID": ["10.3390/cimb45020087"], "Journal": {"ISSN": "1467-3045", "JournalIssue": {"Volume": "45", "Issue": "2", "PubDate": {"Year": "2023", "Month": "Feb", "Day": "05"}}, "Title": "Current issues in molecular biology", "ISOAbbreviation": "Curr Issues Mol Biol"}, "ArticleTitle": "Ozoile Reduces the LPS-Induced Inflammatory Response in Colonic Epithelial Cells and THP-1 Monocytes.", "Pagination": {"StartPage": "1333", "EndPage": "1348", "MedlinePgn": "1333-1348"}, "Abstract": {"AbstractText": ["Inappropriate activation of immune functions in intestinal epithelial cells can lead to inflammation that is characterized also by infiltration into intestinal tissue of monocytes/macrophages. Current therapies for intestinal inflammation include anti-inflammatory, immunosuppressive and biological drugs. Ozoile (stable ozonides) has been reported to exert anti-inflammatory effects. However, ozonated oil has been used mainly for topical applications and no data are available about its effects on intestinal cells or immune cells. In this study, we evaluated Ozoile effects on human HT-29 colonic cells and THP-1 monocytic cells stimulated with LPS to induce inflammation. HT-29 and THP-1 cells were treated with LPS in the presence/absence of Ozoile for 4 h. Biomarkers of inflammation, some members of tight junctions and the adhesion molecule ICAM were assessed by qRT-PCR. Protein expression was analyzed by Western blotting. The release of TNF-\u03b1 and IL-1\u03b2 was measured by ELISA. In HT-29, Ozoile inhibited LPS-induced expression of TNF-\u03b1, IL-1\u03b2, ZO-1, CLDN1, NOS2 and MMP-2 and increased the expression of Nrf2 and SOD2 antioxidant proteins. In THP-1 cells, the LPS induction of TNF-\u03b1, IL-1\u03b2 and ICAM was counteracted by Ozoile treatment. Our in vitro results demonstrate the effectiveness of Ozoile in reducing the inflammatory response in intestinal and monocytic cells. Further in vivo studies are necessary to confirm its possible use for intestinal inflammatory conditions."]}, "AuthorList": [{"Identifier": ["0000-0002-0644-8418"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy."}], "LastName": "Bertuccio", "ForeName": "Maria Paola", "Initials": "MP"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy."}], "LastName": "Rizzo", "ForeName": "Valentina", "Initials": "V"}, {"Identifier": ["0000-0003-0276-9211"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Pediatric Surgery, Department of Human Pathology of Adult and Childhood \"Gaetano Barresi\", University of Messina, 98125 Messina, Italy."}], "LastName": "Arena", "ForeName": "Salvatore", "Initials": "S"}, {"Identifier": ["0000-0003-1734-0354"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy."}], "LastName": "Trainito", "ForeName": "Alessandra", "Initials": "A"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Pediatric Surgery, Department of Human Pathology of Adult and Childhood \"Gaetano Barresi\", University of Messina, 98125 Messina, Italy."}], "LastName": "Montalto", "ForeName": "Angela Simona", "Initials": "AS"}, {"Identifier": ["0000-0001-8593-9495"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy."}], "LastName": "Caccamo", "ForeName": "Daniela", "Initials": "D"}, {"Identifier": ["0000-0001-8852-7023"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Biomedical and Dental Sciences and Morpho-Functional Imaging, University of Messina, 98125 Messina, Italy."}], "LastName": "Curr\u00f2", "ForeName": "Monica", "Initials": "M"}, {"Identifier": ["0000-0002-7616-5480"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Pediatric Surgery, Department of Human Pathology of Adult and Childhood \"Gaetano Barresi\", University of Messina, 98125 Messina, Italy."}], "LastName": "Romeo", "ForeName": "Carmelo", "Initials": "C"}, {"Identifier": ["0000-0003-4262-2433"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Unit of Pediatric Surgery, Department of Human Pathology of Adult and Childhood \"Gaetano Barresi\", University of Messina, 98125 Messina, Italy."}], "LastName": "Impellizzeri", "ForeName": "Pietro", "Initials": "P"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Curr Issues Mol Biol", "NlmUniqueID": "100931761", "ISSNLinking": "1467-3037"}, "CoiStatement": "The authors declare no conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Gianchecchi E., Fierabracci A. Recent Advances on Microbiota Involvement in the Pathogenesis of Autoimmunity. Int. J. Mol. Sci. 2019;20:283. doi: 10.3390/ijms20020283.", "ArticleIdList": ["10.3390/ijms20020283", "PMC6359510", "30642013"]}, {"Citation": "Bramuzzo M., De Carlo C., Arrigo S., Pavanello P.M., Canaletti C., Giudici F., Agrusti A., Martelossi S., Di Leo G., Barbi E. Parental Psychological Factors and Quality of Life of Children with Inflammatory Bowel Disease. J. Pediatr. Gastroenterol. Nutr. 2020;70:211\u2013217. doi: 10.1097/MPG.0000000000002548.", "ArticleIdList": ["10.1097/MPG.0000000000002548", "31978019"]}, {"Citation": "Siegel C.A., Bernstein C.N. Identifying Patients with Inflammatory Bowel Diseases at High vs Low Risk of Complications. Clin. Gastroenterol. Hepatol. 2019;18:1261\u20131267. doi: 10.1016/j.cgh.2019.11.034.", "ArticleIdList": ["10.1016/j.cgh.2019.11.034", "31778805"]}, {"Citation": "Jang H.J., Kang B., Choe B.H. The difference in extraintestinal manifestations of inflammatory bowel disease for children and adults. Transl. Pediatr. 2019;8:4\u201315. doi: 10.21037/tp.2019.01.06.", "ArticleIdList": ["10.21037/tp.2019.01.06", "PMC6382501", "30881893"]}, {"Citation": "Hruz P., Juillerat P., Kullak-Ublick G.A., Schoepfer A.M., Mantzaris G.J., Rogler G. Management of the Elderly Inflammatory Bowel Disease Patient. Digestion. 2020;14:105\u2013119. doi: 10.1159/000503099.", "ArticleIdList": ["10.1159/000503099", "31935714"]}, {"Citation": "Devos S.A., Van Den Bossche N., De Vos M., Naeyaert J.M. Adverse skin reactions to anti-TNF-alpha monoclonal antibody therapy. Dermatology. 2003;206:388\u2013390. doi: 10.1159/000069965.", "ArticleIdList": ["10.1159/000069965", "12771494"]}, {"Citation": "Salaga M., Zatorski H., Sobczak M., Chen C., Fichna J. Chinese herbal medicines in the treatment of IBD and colorectal cancer: A review. Curr. Treat. Options Oncol. 2014;15:405\u2013420. doi: 10.1007/s11864-014-0288-2.", "ArticleIdList": ["10.1007/s11864-014-0288-2", "PMC4147240", "24792017"]}, {"Citation": "Maioli T.U., Trindade L.M., Souza A., Torres L., Andrade M.E.R., Cardoso V.N., Generoso S.V. Non-pharmacologic strategies for the management of intestinal inflammation. Biomed. Pharmacother. 2022;145:112414. doi: 10.1016/j.biopha.2021.112414.", "ArticleIdList": ["10.1016/j.biopha.2021.112414", "34808552"]}, {"Citation": "Galie M., Covi V., Tabaracci G., Malatesta M. The Role of Nrf2 in the Antioxidant Cellular Response to Medical Ozone Exposure. Int. J. Mol. Sci. 2019;20:4009. doi: 10.3390/ijms20164009.", "ArticleIdList": ["10.3390/ijms20164009", "PMC6720777", "31426459"]}, {"Citation": "Sadatullah S., Mohamed N.H., Razak F.A. The antimicrobial effect of 0.1 ppm ozonated water on 24-hour plaque microorganisms in situ. Braz. Oral Res. 2012;26:126\u2013131. doi: 10.1590/S1806-83242012000200007.", "ArticleIdList": ["10.1590/S1806-83242012000200007", "22473347"]}, {"Citation": "Sechi L.A., Lezcano I., Nunez N., Espim M., Dupre I., Pinna A., Molicotti P., Fadda G., Zanetti S. Antibacterial activity of ozonized sunflower oil (Oleozon) J. Appl. Microbiol. 2001;90:279\u2013284. doi: 10.1046/j.1365-2672.2001.01235.x.", "ArticleIdList": ["10.1046/j.1365-2672.2001.01235.x", "11168731"]}, {"Citation": "Uysal B. Ozonated olive oils and the troubles. J. Intercult. Ethnopharmacol. 2014;3:49\u201350. doi: 10.5455/jice.20140314090801.", "ArticleIdList": ["10.5455/jice.20140314090801", "PMC4576797", "26401346"]}, {"Citation": "Elvis A.M., Ekta J.S. Ozone therapy: A clinical review. J. Nat. Sci. Biol. Med. 2011;2:66\u201370. doi: 10.4103/0976-9668.82319.", "ArticleIdList": ["10.4103/0976-9668.82319", "PMC3312702", "22470237"]}, {"Citation": "Holz O., Tal-Singer R., Kanniess F., Simpson K.J., Gibson A., Vessey R.S., Janicki S., Magnussen H., Jorres R.A., Richter K. Validation of the human ozone challenge model as a tool for assessing anti-inflammatory drugs in early development. J. Clin. Pharmacol. 2005;45:498\u2013503. doi: 10.1177/0091270004273527.", "ArticleIdList": ["10.1177/0091270004273527", "15831772"]}, {"Citation": "Braidy N., Izadi M., Sureda A., Jonaidi-Jafari N., Banki A., Nabavi S.F., Nabavi S.M. Therapeutic relevance of ozone therapy in degenerative diseases: Focus on diabetes and spinal pain. J. Cell. Physiol. 2018;233:2705\u20132714. doi: 10.1002/jcp.26044.", "ArticleIdList": ["10.1002/jcp.26044", "28594115"]}, {"Citation": "Curr\u00f2 M., Russo T., Ferlazzo N., Caccamo D., Antonuccio P., Arena S., Parisi S., Perrone P., Ientile R., Romeo C., et al. Anti-Inflammatory and Tissue Regenerative Effects of Topical Treatment with Ozonated Olive Oil/Vitamin E Acetate in Balanitis Xerotica Obliterans. Molecules. 2018;23:645. doi: 10.3390/molecules23030645.", "ArticleIdList": ["10.3390/molecules23030645", "PMC6017296", "29534008"]}, {"Citation": "Russo T., Curro M., Ferlazzo N., Caccamo D., Perrone P., Arena S., Antonelli E., Antonuccio P., Ientile R., Romeo C., et al. Stable Ozonides with Vitamin E Acetate versus Corticosteroid in the Treatment of Lichen Sclerosus in Foreskin: Evaluation of Effects on Inflammation. Urol. Int. 2019;103:459\u2013465. doi: 10.1159/000499846.", "ArticleIdList": ["10.1159/000499846", "30991399"]}, {"Citation": "Ugazio E., Tullio V., Binello A., Tagliapietra S., Dosio F. Ozonated Oils as Antimicrobial Systems in Topical Applications. Their Characterization, Current Applications, and Advances in Improved Delivery Techniques. Molecules. 2020;25:334. doi: 10.3390/molecules25020334.", "ArticleIdList": ["10.3390/molecules25020334", "PMC7024311", "31947580"]}, {"Citation": "Kato Y., Sakoh M., Nagai T., Yoshida A., Ishida H., Inoue N., Yanagita T., Nagao K. Ozonated Olive Oil Alleviates Hepatic Steatosis in Obese Zucker (fa/fa) Rats. J. Oleo Sci. 2022;71:599\u2013607. doi: 10.5650/jos.ess21377.", "ArticleIdList": ["10.5650/jos.ess21377", "35283416"]}, {"Citation": "Sun Y., Liu Z., Song S., Zhu B., Zhao L., Jiang J., Liu N., Wang J., Chen X. Anti-inflammatory activity and structural identification of a sulfated polysaccharide CLGP4 from Caulerpa lentillifera. Int. J. Biol. Macromol. 2020;146:931\u2013938. doi: 10.1016/j.ijbiomac.2019.09.216.", "ArticleIdList": ["10.1016/j.ijbiomac.2019.09.216", "31730965"]}, {"Citation": "Byun E.B., Kim W.S., Sung N.Y., Byun E.H. Epigallocatechin-3-Gallate Regulates Anti-Inflammatory Action through 67-kDa Laminin Receptor-Mediated Tollip Signaling Induction in Lipopolysaccharide-Stimulated Human Intestinal Epithelial Cells. Cell. Physiol. Biochem. 2018;46:2072\u20132081. doi: 10.1159/000489447.", "ArticleIdList": ["10.1159/000489447", "29723847"]}, {"Citation": "Yurinskaya M.M., Krasnov G.S., Kulikova D.A., Zatsepina O.G., Vinokurov M.G., Chuvakova L.N., Rezvykh A.P., Funikov S.Y., Morozov A.V., Evgen\u2019ev M.B. H2S counteracts proinflammatory effects of LPS through modulation of multiple pathways in human cells. Inflamm. Res. 2020;69:481\u2013495. doi: 10.1007/s00011-020-01329-x.", "ArticleIdList": ["10.1007/s00011-020-01329-x", "32157318"]}, {"Citation": "Mapa M.S.T., Araujo M., Zhao Y., Flynn T., Sprando J., Wiesenfeld P., Sprando R.L., Mossoba M.E. A method to dissolve 3-MCPD mono- and di-esters in aqueous cell culture media. MethodsX. 2020;7:100774. doi: 10.1016/j.mex.2019.100774.", "ArticleIdList": ["10.1016/j.mex.2019.100774", "PMC7046810", "32140439"]}, {"Citation": "Rizzo V., Ferlazzo N., Curro M., Isola G., Matarese M., Bertuccio M.P., Caccamo D., Matarese G., Ientile R. Baicalin-Induced Autophagy Preserved LPS-Stimulated Intestinal Cells from Inflammation and Alterations of Paracellular Permeability. Int. J. Mol. Sci. 2021;22:2315. doi: 10.3390/ijms22052315.", "ArticleIdList": ["10.3390/ijms22052315", "PMC7956379", "33652555"]}, {"Citation": "Risitano R., Curro M., Cirmi S., Ferlazzo N., Campiglia P., Caccamo D., Ientile R., Navarra M. Flavonoid fraction of Bergamot juice reduces LPS-induced inflammatory response through SIRT1-mediated NF-kappaB inhibition in THP-1 monocytes. PLoS ONE. 2014;9:e107431. doi: 10.1371/journal.pone.0107431.", "ArticleIdList": ["10.1371/journal.pone.0107431", "PMC4178028", "25260046"]}, {"Citation": "Stolfi C., Maresca C., Monteleone G., Laudisi F. Implication of Intestinal Barrier Dysfunction in Gut Dysbiosis and Diseases. Biomedicines. 2022;10:289. doi: 10.3390/biomedicines10020289.", "ArticleIdList": ["10.3390/biomedicines10020289", "PMC8869546", "35203499"]}, {"Citation": "Di Mauro R., Cantarella G., Bernardini R., Di Rosa M., Barbagallo I., Distefano A., Longhitano L., Vicario N., Nicolosi D., Lazzarino G., et al. The Biochemical and Pharmacological Properties of Ozone: The Smell of Protection in Acute and Chronic Diseases. Int. J. Mol. Sci. 2019;20:634. doi: 10.3390/ijms20030634.", "ArticleIdList": ["10.3390/ijms20030634", "PMC6387239", "30717203"]}, {"Citation": "Kim H.S., Noh S.U., Han Y.W., Kim K.M., Kang H., Kim H.O., Park Y.M. Therapeutic effects of topical application of ozone on acute cutaneous wound healing. J. Korean Med. Sci. 2009;24:368\u2013374. doi: 10.3346/jkms.2009.24.3.368.", "ArticleIdList": ["10.3346/jkms.2009.24.3.368", "PMC2698179", "19543419"]}, {"Citation": "Pai S.A., Gagangras S.A., Kulkarni S.S., Majumdar A.S. Potential of ozonated sesame oil to augment wound healing in rats. Indian J. Pharm. Sci. 2014;76:87\u201392.", "ArticleIdList": ["PMC4007261", "24799744"]}, {"Citation": "Altinel O., Demirbas S., Cakir E., Yaman H., Ozerhan I.H., Duran E., Cayci T., Akgul E.O., Ersoz N., Uysal B., et al. Comparison of hyperbaric oxygen and medical ozone therapies in a rat model of experimental distal colitis. Scand. J. Clin. Lab. Invest. 2011;71:185\u2013192. doi: 10.3109/00365513.2010.548875.", "ArticleIdList": ["10.3109/00365513.2010.548875", "21198421"]}, {"Citation": "Geng Y., Wang W., Ma Q., Peng L.Q., Liang Z.H. Ozone therapy combined with sulfasalazine delivered via a colon therapy system for treatment of ulcerative colitis. Nan Fang Yi Ke Da Xue Xue Bao. 2010;30:2683\u20132685.", "ArticleIdList": ["21177179"]}, {"Citation": "Neurath M.F. Cytokines in inflammatory bowel disease. Nat. Rev. Immunol. 2014;14:329\u2013342. doi: 10.1038/nri3661.", "ArticleIdList": ["10.1038/nri3661", "24751956"]}, {"Citation": "Yamamoto-Furusho J.K. Inflammatory bowel disease therapy: Blockade of cytokines and cytokine signaling pathways. Curr. Opin. Gastroenterol. 2018;34:187\u2013193. doi: 10.1097/MOG.0000000000000444.", "ArticleIdList": ["10.1097/MOG.0000000000000444", "29846261"]}, {"Citation": "Chelakkot C., Ghim J., Ryu S.H. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp. Mol. Med. 2018;50:1\u20139. doi: 10.1038/s12276-018-0126-x.", "ArticleIdList": ["10.1038/s12276-018-0126-x", "PMC6095905", "30115904"]}, {"Citation": "Eslamian G., Ardehali S.H., Hajimohammadebrahim-Ketabforoush M., Vahdat Shariatpanahi Z. Association of intestinal permeability with admission vitamin D deficiency in patients who are critically ill. J. Investig. Med. 2020;68:397\u2013402. doi: 10.1136/jim-2019-001132.", "ArticleIdList": ["10.1136/jim-2019-001132", "31672717"]}, {"Citation": "Malickova K., Francova I., Lukas M., Kolar M., Kralikova E., Bortlik M., Duricova D., Stepankova L., Zvolska K., Pankova A., et al. Fecal zonulin is elevated in Crohn\u2019s disease and in cigarette smokers. Pract. Lab. Med. 2017;9:39\u201344. doi: 10.1016/j.plabm.2017.09.001.", "ArticleIdList": ["10.1016/j.plabm.2017.09.001", "PMC5633835", "29034305"]}, {"Citation": "Sturgeon C., Lan J., Fasano A. Zonulin transgenic mice show altered gut permeability and increased morbidity/mortality in the DSS colitis model. Ann. N. Y. Acad. Sci. 2017;1397:130\u2013142. doi: 10.1111/nyas.13343.", "ArticleIdList": ["10.1111/nyas.13343", "PMC5479715", "28423466"]}, {"Citation": "Weber C.R., Nalle S.C., Tretiakova M., Rubin D.T., Turner J.R. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab. Invest. 2008;88:1110\u20131120. doi: 10.1038/labinvest.2008.78.", "ArticleIdList": ["10.1038/labinvest.2008.78", "PMC2586671", "18711353"]}, {"Citation": "Guihot G., Guimbaud R., Bertrand V., Narcy-Lambare B., Couturier D., Duee P.H., Chaussade S., Blachier F. Inducible nitric oxide synthase activity in colon biopsies from inflammatory areas: Correlation with inflammation intensity in patients with ulcerative colitis but not with Crohn\u2019s disease. Amino Acids. 2000;18:229\u2013237. doi: 10.1007/s007260050020.", "ArticleIdList": ["10.1007/s007260050020", "10901620"]}, {"Citation": "Rafa H., Saoula H., Belkhelfa M., Medjeber O., Soufli I., Toumi R., de Launoit Y., Morales O., Nakmouche M., Delhem N., et al. IL-23/IL-17A axis correlates with the nitric oxide pathway in inflammatory bowel disease: Immunomodulatory effect of retinoic acid. J. Interferon Cytokine Res. 2013;33:355\u2013368. doi: 10.1089/jir.2012.0063.", "ArticleIdList": ["10.1089/jir.2012.0063", "23472658"]}, {"Citation": "Soufli I., Toumi R., Rafa H., Touil-Boukoffa C. Overview of cytokines and nitric oxide involvement in immuno-pathogenesis of inflammatory bowel diseases. World J. Gastrointest. Pharmacol. Ther. 2016;7:353\u2013360. doi: 10.4292/wjgpt.v7.i3.353.", "ArticleIdList": ["10.4292/wjgpt.v7.i3.353", "PMC4986402", "27602236"]}, {"Citation": "Mao J.W., Tang H.Y., Tan X.Y., Wang Y.D. Effect of Etiasa on the expression of matrix metalloproteinase-2 and tumor necrosis factor-alpha in a rat model of ulcerative colitis. Mol. Med. Rep. 2012;6:996\u20131000. doi: 10.3892/mmr.2012.1021.", "ArticleIdList": ["10.3892/mmr.2012.1021", "22895819"]}, {"Citation": "Sim W.H., Wagner J., Cameron D.J., Catto-Smith A.G., Bishop R.F., Kirkwood C.D. Expression profile of genes involved in pathogenesis of pediatric Crohn\u2019s disease. J. Gastroenterol. Hepatol. 2012;27:1083\u20131093. doi: 10.1111/j.1440-1746.2011.06973.x.", "ArticleIdList": ["10.1111/j.1440-1746.2011.06973.x", "PMC7167032", "22098497"]}, {"Citation": "Ravi A., Garg P., Sitaraman S.V. Matrix metalloproteinases in inflammatory bowel disease: Matrix metalloproteinases in inflammatory bowel disease: Boon or a bane? Inflamm. Bowel. Dis. 2007;13:97\u2013107. doi: 10.1002/ibd.20011.", "ArticleIdList": ["10.1002/ibd.20011", "17206645"]}, {"Citation": "Galie M., Costanzo M., Nodari A., Boschi F., Calderan L., Mannucci S., Covi V., Tabaracci G., Malatesta M. Mild ozonisation activates antioxidant cell response by the Keap1/Nrf2 dependent pathway. Free Radic. Biol. Med. 2018;124:114\u2013121. doi: 10.1016/j.freeradbiomed.2018.05.093.", "ArticleIdList": ["10.1016/j.freeradbiomed.2018.05.093", "29864481"]}, {"Citation": "Li W., Kong A.N. Molecular mechanisms of Nrf2-mediated antioxidant response. Mol. Carcinog. 2009;48:91\u2013104. doi: 10.1002/mc.20465.", "ArticleIdList": ["10.1002/mc.20465", "PMC2631094", "18618599"]}, {"Citation": "Niture S.K., Khatri R., Jaiswal A.K. Regulation of Nrf2-an update. Free Radic. Biol. Med. 2014;66:36\u201344. doi: 10.1016/j.freeradbiomed.2013.02.008.", "ArticleIdList": ["10.1016/j.freeradbiomed.2013.02.008", "PMC3773280", "23434765"]}, {"Citation": "Ahmed S.M., Luo L., Namani A., Wang X.J., Tang X. Nrf2 signaling pathway: Pivotal roles in inflammation. Biochim. Biophys. Acta Mol. Basis Dis. 2017;1863:585\u2013597. doi: 10.1016/j.bbadis.2016.11.005.", "ArticleIdList": ["10.1016/j.bbadis.2016.11.005", "27825853"]}, {"Citation": "Lee S.H., Sohn D.H., Jin X.Y., Kim S.W., Choi S.C., Seo G.S. 2\u2032,4\u2032,6\u2032-tris(methoxymethoxy) chalcone protects against trinitrobenzene sulfonic acid-induced colitis and blocks tumor necrosis factor-alpha-induced intestinal epithelial inflammation via heme oxygenase 1-dependent and independent pathways. Biochem. Pharmacol. 2007;74:870\u2013880. doi: 10.1016/j.bcp.2007.06.034.", "ArticleIdList": ["10.1016/j.bcp.2007.06.034", "17678632"]}, {"Citation": "Piotrowska M., Swierczynski M., Fichna J., Piechota-Polanczyk A. The Nrf2 in the pathophysiology of the intestine: Molecular mechanisms and therapeutic implications for inflammatory bowel diseases. Pharmacol. Res. 2021;163:105243. doi: 10.1016/j.phrs.2020.105243.", "ArticleIdList": ["10.1016/j.phrs.2020.105243", "33080322"]}, {"Citation": "Jones G.R., Bain C.C., Fenton T.M., Kelly A., Brown S.L., Ivens A.C., Travis M.A., Cook P.C., MacDonald A.S. Dynamics of Colon Monocyte and Macrophage Activation During Colitis. Front. Immunol. 2018;9:2764. doi: 10.3389/fimmu.2018.02764.", "ArticleIdList": ["10.3389/fimmu.2018.02764", "PMC6277765", "30542349"]}, {"Citation": "Xiong J., Lin Y.H., Bi L.H., Wang J.D., Bai Y., Liu S.D. Effects of interleukin-4 or interleukin-10 gene therapy on trinitrobenzenesulfonic acid-induced murine colitis. BMC Gastroenterol. 2013;13:165. doi: 10.1186/1471-230X-13-165.", "ArticleIdList": ["10.1186/1471-230X-13-165", "PMC3897998", "24314293"]}, {"Citation": "Jayme T.S., Leung G., Wang A., Workentine M.L., Rajeev S., Shute A., Callejas B.E., Mancini N., Beck P.L., Panaccione R., et al. Human interleukin-4-treated regulatory macrophages promote epithelial wound healing and reduce colitis in a mouse model. Sci. Adv. 2020;6:eaba4376. doi: 10.1126/sciadv.aba4376.", "ArticleIdList": ["10.1126/sciadv.aba4376", "PMC7274799", "32548267"]}, {"Citation": "Bamias G., Clark D.J., Rivera-Nieves J. Leukocyte traffic blockade as a therapeutic strategy in inflammatory bowel disease. Curr. Drug Targets. 2013;14:1490\u20131500. doi: 10.2174/13894501113149990158.", "ArticleIdList": ["10.2174/13894501113149990158", "PMC3779486", "23621509"]}, {"Citation": "Bailey M.J., Naik N.N., Wild L.E., Patterson W.B., Alderete T.L. Exposure to air pollutants and the gut microbiota: A potential link between exposure, obesity, and type 2 diabetes. Gut Microbes. 2020;11:1188\u20131202. doi: 10.1080/19490976.2020.1749754.", "ArticleIdList": ["10.1080/19490976.2020.1749754", "PMC7524284", "32347153"]}, {"Citation": "Snow S.J., Broniowska K., Karoly E.D., Henriquez A.R., Phillips P.M., Ledbetter A.D., Schladweiler M.C., Miller C.N., Gordon C.J., Kodavanti U.P. Offspring susceptibility to metabolic alterations due to maternal high-fat diet and the impact of inhaled ozone used as a stressor. Sci. Rep. 2020;10:16353. doi: 10.1038/s41598-020-73361-0.", "ArticleIdList": ["10.1038/s41598-020-73361-0", "PMC7530537", "33004997"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "12", "Day": "23"}, {"Year": "2023", "Month": "1", "Day": "31"}, {"Year": "2023", "Month": "2", "Day": "2"}, {"Year": "2023", "Month": "2", "Day": "24", "Hour": "9", "Minute": "33"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "6", "Minute": "0"}, {"Year": "2023", "Month": "2", "Day": "25", "Hour": "6", "Minute": "1"}, {"Year": "2023", "Month": "2", "Day": "5"}], "PublicationStatus": "epublish", "ArticleIdList": ["36826032", "PMC9955553", "10.3390/cimb45020087", "cimb45020087"]}}], "PubmedBookArticle": []}